HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lineage specific demethylation of tal-1 gene breakpoint region determines the frequency of tal-1 deletions in alpha beta lineage T-cells.

Abstract
tal-1 deletions are caused by a site specific recombination, which exclusively occurs in 12-26% of T-cell acute lymphoblastic leukemias (T-ALL). In a previous study on a large series of T-ALL we demonstrated an apparent preferential occurrence of tal-1 deletions in CD3- and CD3+ alpha beta lineage T-ALL with TcR-delta gene deletions on one or both alleles. In the present study we investigated whether accessibility of the tal-1 deletion breakpoint regions influences the preferential occurrence in specific T-ALL subgroups. Because DNA methylation is assumed to determine accessibility of DNA for recombination, the methylation status of the tal-1 deletion type 1 breakpoint regions (sildb and taldb1) was studied. Although the sildb were completely demethylated in all T-ALL, preferential (de)methylation configurations of the taldb1 were observed in the analysed 119 T-ALL. Most TcR-alpha beta + T-ALL contained completely demethylated taldb1 (77%), whereas in most TcR-gamma delta + T-ALL partial or complete methylation occurred (42% and 47%, respectively). In T-ALL subgroups defined by different TcR-delta gene configurations also preferential taldb1 (de)methylation patterns were seen, which was most prominent in T-ALL with both TcR-delta genes deleted (84% complete demethylation). The previously observed preferential occurrence of tal-1 deletion type 1 in TcR-alpha beta + vs CD3- T-ALL and in T-ALL with both vs one TcR-delta genes deleted, disappeared when we retricted to T-ALL with completely demethylated taldb1. Moreover, all T-ALL with a tal-1 deletion type 1 (n = 15) contained completely demethylated taldb1. We therefore conclude that complete demethylation of taldb1 is a prerequisite for tal-1 deletions type 1 and that the differences in tal-1 deletion frequencies observed in the various T-ALL subgroups are caused by differences in the (de)methylation status of taldb1 in these subgroups.
AuthorsT M Breit, I L Wolvers-Tettero, J J van Dongen
JournalOncogene (Oncogene) Vol. 9 Issue 7 Pg. 1847-53 (Jul 1994) ISSN: 0950-9232 [Print] England
PMID8208530 (Publication Type: Journal Article)
Chemical References
  • Basic Helix-Loop-Helix Transcription Factors
  • CD3 Complex
  • DNA Primers
  • DNA, Neoplasm
  • DNA-Binding Proteins
  • Intracellular Signaling Peptides and Proteins
  • Oncogene Proteins, Fusion
  • Proteins
  • Proto-Oncogene Proteins
  • Receptors, Antigen, T-Cell, alpha-beta
  • Receptors, Antigen, T-Cell, gamma-delta
  • STIL protein, human
  • T-Cell Acute Lymphocytic Leukemia Protein 1
  • Transcription Factors
  • TAL1 protein, human
Topics
  • Base Sequence
  • Basic Helix-Loop-Helix Transcription Factors
  • CD3 Complex (genetics, metabolism)
  • Cells, Cultured
  • Child
  • DNA Primers
  • DNA, Neoplasm (metabolism)
  • DNA-Binding Proteins (genetics, metabolism)
  • Gene Deletion
  • Humans
  • Intracellular Signaling Peptides and Proteins
  • Leukemia, B-Cell (metabolism)
  • Leukemia, Myeloid, Acute (metabolism)
  • Leukemia, T-Cell (metabolism)
  • Methylation
  • Molecular Sequence Data
  • Oncogene Proteins, Fusion
  • Phenotype
  • Proteins (genetics, metabolism)
  • Proto-Oncogene Proteins
  • Receptors, Antigen, T-Cell, alpha-beta (genetics)
  • Receptors, Antigen, T-Cell, gamma-delta (genetics)
  • T-Cell Acute Lymphocytic Leukemia Protein 1
  • T-Lymphocytes (metabolism)
  • Transcription Factors
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: